Morepen Laboratories plans to launch loratidine in the US market in December this year. The company hopes to achieve a turnover of at least Rs 200 crore from the anti-histaminic drug in the first year itself.
Top Section
Explore Business Standard
Top Section
Explore Business Standard
Don’t miss the latest developments in business and finance.
Morepen Laboratories plans to launch loratidine in the US market in December this year. The company hopes to achieve a turnover of at least Rs 200 crore from the anti-histaminic drug in the first year itself.
First Published: Jun 08 2002 | 12:00 AM IST